Concepedia

Fibroblast Growth Factor 23 in Chronic Kidney Disease: Bridging the Gap between Bone Mineral Metabolism and Left Ventricular Hypertrophy

María Eugênia Fernandes Canziani, Cristianne Tomiyama, Andrea Higa, Sérgio Antônio Draibe, Aluízio B. Carvalho

Blood Purification · 2010 · 37 citations · 30 references

DOI

Abstract

We confirmed the high prevalence of LVH in nondialyzed CKD patients and showed that FGF23, an early marker of phosphorus load, was an important factor associated with LVH in these patients. Monitoring of FGF23 could be important for the management of LVH in this population.

References

30

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey, Josef Coresh, Kline Bolton et al. · Data Archiving and Networked Services (DANS) · 2002 · 11.7K citations

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

David J. Sahn, A N Demaria, Joseph Kisslo et al. · Circulation · 1978 · 7.5K citations · Full text

, , +20

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Daniel Levy, Robert J. Garrison, Daniel D. Savage et al. · New England Journal of Medicine · 1990 · 5.7K citations · Full text

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

Orlando M. Gutiérrez, Michael Mannstadt, Tamara Isakova et al. · New England Journal of Medicine · 2008 · 1.7K citations · Full text

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

Robert N. Foley, Patrick S. Parfrey, John D. Harnett et al. · Kidney International · 1995 · 1.3K citations

, , +11